Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Neon Therapeutics, Inc. (NTGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/18/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
05/14/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/06/2020 4 Zausner Meryl (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
Disposed/sold 40,000 options to buy @ $9.65, valued at $386k
Disposed/sold 14,000 options to buy @ $16, valued at $224k
05/06/2020 4 TEPPER ROBERT I (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 9,741,636 shares @ $0
Disposed/sold 14,000 options to buy @ $16, valued at $224k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
05/06/2020 4 SHERWIN STEPHEN A (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 45,000 shares @ $0
Disposed/sold 14,000 options to buy @ $16, valued at $224k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
Disposed/sold 5,000 options to buy @ $2.65, valued at $13.3k
05/06/2020 4 Pfeffer Cary (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 14,000 options to buy @ $16, valued at $224k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
05/06/2020 4 LANDER ERIC S (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 134,000 shares @ $0
Disposed/sold 14,000 options to buy @ $16, valued at $224k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
05/06/2020 4 Kamen Robert (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 14,000 options to buy @ $16, valued at $224k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
05/06/2020 4 Bazemore Robert B (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 28,000 options to buy @ $7.56, valued at $211.7k
Disposed/sold 18,500 options to buy @ $4.64, valued at $85.8k
05/06/2020 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 210,410 shares @ $0
Disposed/sold 58,005 options to buy @ $10.2, valued at $591.7k
Disposed/sold 105,000 options to buy @ $6.13, valued at $643.7k
Disposed/sold 155,373 options to buy @ $2.65, valued at $411.7k
05/06/2020 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 161,821 shares @ $0
Disposed/sold 60,000 options to buy @ $6.13, valued at $367.8k
Disposed/sold 100,000 options to buy @ $12, valued at $1.2M
05/06/2020 4 Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 196,965 shares @ $0
Disposed/sold 192,759 options to buy @ $5.8, valued at $1.1M
Disposed/sold 61,031 options to buy @ $10.2, valued at $622.5k
Disposed/sold 100,000 options to buy @ $6.13, valued at $613k
05/06/2020 4 O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 776,085 shares @ $0
Disposed/sold 208,062 options to buy @ $10.2, valued at $2.1M
Disposed/sold 200,000 options to buy @ $6.13, valued at $1.2M
Disposed/sold 354,632 options to buy @ $2.65, valued at $939.8k
05/06/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/06/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/06/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/06/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/06/2020 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of the Company",
"Senior Manager Global External Communications"
05/06/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/05/2020 8-K Submission of Matters to a Vote of Security Holders
05/01/2020 10-Q Quarterly Report for the period ended March 31, 2020
04/29/2020 8-K Other Events
04/29/2020 425 Form 425 - Prospectuses and communications, business combinations:
04/21/2020 10-K/A Annual Report for the period ended December 31, 2019 [amend]
04/02/2020 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
04/02/2020 SC 13D/A Access Industries Holdings LLC reports a 7.5% stake in Neon Therapeutics, Inc.
03/31/2020 425 Form 425 - Prospectuses and communications, business combinations:
03/31/2020 425 Form 425 - Prospectuses and communications, business combinations:
03/31/2020 425 Form 425 - Prospectuses and communications, business combinations:
03/27/2020 SC 13D/A Access Industries Holdings LLC reports a 8.8% stake in Neon Therapeutics, Inc.
03/25/2020 4 Access Industries Holdings LLC (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Sold 117,400 shares @ $2.2022, valued at $258.5k
Sold 84,286 shares @ $2.1923, valued at $184.8k
Sold 50,358 shares @ $2.1741, valued at $109.5k
03/23/2020 4 Access Industries Holdings LLC (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Sold 84,339 shares @ $2.2161, valued at $186.9k
Sold 9,050 shares @ $2.5149, valued at $22.8k
03/23/2020 SC 13G JFL Capital Management LP reports a 5.3% stake in Neon Therapeutics, Inc.
03/02/2020 4 Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,845 shares @ $1.5, valued at $4.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy